Lomexin 20 mg/g 30 ml cutaneous spray solution

Lomexin 20 mg/g 30 ml cutaneous spray solution is a topical antifungal formulated for the effective treatment of skin mycoses and fungal skin infections . Thanks to its active ingredient, 2% fenticonazole nitrate , Lomexin spray acts rapidly against a wide range of pathogens responsible for dermatomycosis (such as Trichophyton, Microsporum, Epidermophyton ), cutaneous candidiasis and pityriasis versicolor . Its cutaneous solution in a 30 ml bottle with nebulizer ensures easy application even on hard-to-reach areas and on hairy areas, such as the scalp .

Lomexin spray is particularly indicated for the treatment of fungal skin infections such as tinea capitis , tinea corporis , tinea pedis (athlete's foot), tinea cruris , tinea manuum , tinea faciei , tinea barbae and tinea unguium . It is also effective against skin candidiasis (intertrigo, diaper candidiasis, perleche, facial, perineal and scrotal candidiasis), balanitis , balanoposthitis , onychia and paronychia . The spray formulation allows for uniform distribution of the product, without greasing or staining the skin or clothes, and is easily removable with water.

The presence of propylene glycol among the excipients helps improve the skin penetration of the active ingredient, while the alcoholic solution promotes rapid drying. Lomexin 20 mg/g cutaneous spray solution is the ideal choice for those looking for a practical, rapid and targeted treatment of skin mycoses , ensuring effective action against the main dermatophyte fungi and yeasts responsible for skin infections.

ACTIVE INGREDIENTS

Active substances contained in Lomexin 20 mg/g 30 ml cutaneous spray solution - What is the active substance of Lomexin 20 mg/g 30 ml cutaneous spray solution?

Lomexin 2% cream 100 g of cream contain 2 g of fenticonazole nitrate. Excipients with known effect: 100 g of cream contain 5 g of propylene glycol, 3 g of cetyl alcohol, 1 g of hydrogenated lanolin. Lomexin 2% cutaneous spray, solution 100 ml of solution contain 2 g of fenticonazole nitrate. Excipient with known effect: 100 ml of solution contain 35 g of propylene glycol. Lomexin 2% cutaneous solution 100 ml of solution contain 2 g of fenticonazole nitrate. Excipient with known effect: 100 ml of solution contain 77.50 g of propylene glycol. Lomexin 1% cutaneous powder 100 g of powder contain 1 g of fenticonazole nitrate. Lomexin 2% cutaneous powder 100 g of powder contain 2 g of fenticonazole nitrate. For a full list of excipients, see section 6.1.

EXCIPIENTS

Composition of Lomexin 20 mg/g 30 ml cutaneous spray solution - What does Lomexin 20 mg/g 30 ml cutaneous spray solution contain?

Lomexin 2% cream Propylene glycol Hydrogenated lanolin Refined almond oil Polyglycol ester of fatty acids Cetyl alcohol Glyceryl monostearate Sodium edetate Purified water. Lomexin 2% skin spray, solution Alcohol Propylene glycol Purified water. Lomexin 2% skin solution Alcohol Hydroxypropylcellulose Purified water Propylene glycol. Lomexin 1% skin powder Hydrated colloidal silica Zinc oxide Talc. Lomexin 2% skin powder Hydrated colloidal silica Zinc oxide Talc.

DIRECTIONS

Therapeutic indications Lomexin 20 mg/g 30 ml cutaneous spray solution - Why is Lomexin 20 mg/g 30 ml cutaneous spray solution used? What is it used for?

Lomexin 2% cream, Lomexin 2% skin spray, solution, Lomexin 2% skin solution, Lomexin 1% and 2% skin powder: • Dermatomycosis caused by dermatophytes ( Trichophyton, Microsporum, Epidermophyton ) at different locations: tinea capitis, tinea corporis, tinea cruris, tinea pedis (athlete's foot), tinea manuum, tinea faciei, tinea barbae, tinea unguium . – Skin candidiasis (intertrigo, perleche, facial candidiasis, "diaper" candidiasis, perineal and scrotal candidiasis); balanitis, balanoposthitis; onychia and paronychia. – Pityriasis versicolor (caused by Pityrosporum orbiculare and P. ovale ). – Otomycosis (caused by Candida or mould); only if there are no lesions of the eardrum. – Erythrasma. – Mycosis with bacterial superinfections (from Gram-positive bacteria).

CONTRAINDICATIONS AND SIDE EFFECTS

Contraindications Lomexin 20 mg/g 30 ml cutaneous spray solution - When should Lomexin 20 mg/g 30 ml cutaneous spray solution not be used?

Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Pregnancy (see section 4.6).

DOSAGE

Quantity and method of taking Lomexin 20 mg/g 30 ml cutaneous spray solution - How to take Lomexin 20 mg/g 30 ml cutaneous spray solution?

Lomexin should be applied 1–2 times a day, according to the doctor's advice, after washing and drying the affected area, using the formulation suitable for the location of the lesion. Lomexin 2% cream – is indicated for the treatment of hairless skin, skin folds and mucous membranes; it is applied by lightly rubbing. It is used preferably for dry mycoses: pityriasis versicolor, erythrasma, onychomycosis (in onychomycosis the cream should be applied with an occlusive dressing); the cream is suitable for use in male genital mycoses. Lomexin 2% skin spray, solution and 2% skin solution – are indicated for localizations on the scalp and for skin areas covered with hair. The skin spray solution is also easy and convenient to use for extensive mycoses and for areas that are difficult to reach. Lomexin 1% and 2% skin powder – is used for athlete's foot and in general for intertriginous areas and for moist lesions, both as a single treatment and as a complement to the cream. In case of foot infections, it is recommended to sprinkle Lomexin powder also on the inside of socks and shoes. Lomexin 1% skin powder is indicated for the prophylaxis of reinfections. In case of athlete's foot and onychomycosis, in order to avoid reinfections, it is advisable to continue the above treatment for another one or two weeks after the disappearance of the symptoms. Lomexin is not greasy, does not stain and is easily removable with water.

CONSERVATION

Storage Lomexin 20 mg/g 30 ml cutaneous spray solution - How is Lomexin 20 mg/g 30 ml cutaneous spray solution stored?

None.

WARNINGS

Warnings Lomexin 20 mg/g 30 ml cutaneous spray solution - About Lomexin 20 mg/g 30 ml cutaneous spray solution it is important to know that:

Upon application to the lesion, a slight burning sensation may be felt which disappears quickly. The use, especially if prolonged, of products for topical use may give rise to sensitization phenomena. In this case, discontinue treatment and consult your doctor to establish appropriate therapy. Important information about some excipients: Lomexin 2% cream, Lomexin 2% cutaneous spray, solution, Lomexin 2% cutaneous solution contain propylene glycol. They may cause skin irritation. Lomexin 2% cream contains cetyl alcohol. It may cause local skin reactions (e.g. contact dermatitis). Lomexin 2% cream contains hydrogenated lanolin. It may cause local skin reactions (e.g. contact dermatitis).

INTERACTIONS

Interactions Lomexin 20 mg/g 30 ml cutaneous spray solution - Which medicines or foods can modify the effect of Lomexin 20 mg/g 30 ml cutaneous spray solution?

None known.

SIDE EFFECTS

Like all medicines, Lomexin 20 mg/g 30 ml cutaneous spray solution can cause side effects - What are the side effects of Lomexin 20 mg/g 30 ml cutaneous spray solution?

When used as recommended, Lomexin is only poorly absorbed and no systemic side effects are expected. Prolonged use of topical products may cause sensitization phenomena (see section 4.4). The table below lists the undesirable effects, listed by MedDRA system organ class and by frequency: very common (≥1/10); common (≥1/100, <1/10); uncommon (≥1/1,000, <1/100); rare (≥1/10,000, <1/1,000); very rare (<1/10,000); not known (frequency cannot be estimated from the available data).

Classification by systems and organs	Frequency	Preferred term
Skin and subcutaneous tissue disorders	Very rare	Erythema, Itching, Rash, Erythematous rash, Skin irritation, Burning sensation of the skin

Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it/it/responsabili .

OVERDOSE

Overdose Lomexin 20 mg/g 30 ml cutaneous spray solution - What are the risks of Lomexin 20 mg/g 30 ml cutaneous spray solution in case of overdose?

No cases of overdose have been reported.

PREGNANCY AND BREASTFEEDING

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Lomexin 20 mg/g 30 ml cutaneous spray solution.

Although percutaneous absorption of fenticonazole is rather poor, it is advisable not to use the drug during pregnancy.

DRIVING AND USE OF MACHINERY

Taking Lomexin 20 mg/g 30 ml cutaneous spray solution before driving or using machines - Does Lomexin 20 mg/g 30 ml cutaneous spray solution affect driving or using machines?

Lomexin does not alter the ability to drive vehicles or use machines.